The FDA just ap­proved the 46th new drug of the year — a record high for the past decade

The FDA just reached in­to the line­up of drugs in the queue for a Q1 PDU­FA date — again — and picked out La Jol­la Phar­ma­ceu­ti­cal’s drug for dan­ger­ous­ly low blood pres­sure to give it a record 46th new drug ap­proval for the year.

!func­tion(e,t,s,i){var n=”In­fo­gramEm­beds”,o=e.getEle­ments­By­Tag­Name(“script”),d=o[0],r=/^http:/.test(e.lo­ca­tion)?”http:”:”https:”;if(/^\/{2}/.test(i)&&(i=r+i),win­dow[n]&&win­dow[n].ini­tial­ized)win­dow[n].process&&win­dow[n].process();else if(!e.getEle­ment­ById(s)){var a=e.cre­ateEle­ment(“script”);a.async=1,a.id=s,a.src=i,d.par­entN­ode.in­sert­Be­fore(a,d)}}(doc­u­ment,0,”in­fo­gram-async”,”https://e.in­fo­gram.com/js/dist/em­bed-loader-min.js”);

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER